Literature DB >> 25186263

The impact of novel tests for tuberculosis depends on the diagnostic cascade.

Amanda Y Sun1, Claudia M Denkinger2, David W Dowdy3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25186263      PMCID： PMC4254765          DOI： 10.1183/09031936.00111014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia.

Authors:  Amanda Y Sun; Madhukar Pai; Henrik Salje; Srinath Satyanarayana; Sarang Deo; David W Dowdy
Journal:  Am J Epidemiol       Date:  2013-10-07       Impact factor: 4.897

2.  Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.

Authors:  Grant Theron; Lynn Zijenah; Duncan Chanda; Petra Clowes; Andrea Rachow; Maia Lesosky; Wilbert Bara; Stanley Mungofa; Madhukar Pai; Michael Hoelscher; David Dowdy; Alex Pym; Peter Mwaba; Peter Mason; Jonny Peter; Keertan Dheda
Journal:  Lancet       Date:  2013-10-28       Impact factor: 79.321

3.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

Review 4.  Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.

Authors:  Karin Weyer; Fuad Mirzayev; Giovanni Battista Migliori; Wayne Van Gemert; Lia D'Ambrosio; Matteo Zignol; Katherine Floyd; Rosella Centis; Daniela M Cirillo; Enrico Tortoli; Chris Gilpin; Jean de Dieu Iragena; Dennis Falzon; Mario Raviglione
Journal:  Eur Respir J       Date:  2012-11-22       Impact factor: 16.671

5.  Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.

Authors:  Roland Diel; Robert Loddenkemper; Jean-Pierre Zellweger; Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Marieke J van der Werf; Masoud Dara; Anne Detjen; Peter Gondrie; Lee Reichman; Francesco Blasi; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2013-02-08       Impact factor: 16.671

6.  Tuberculosis elimination: theory and practice in Europe.

Authors:  Lia D'Ambrosio; Masoud Dara; Marina Tadolini; Rosella Centis; Giovanni Sotgiu; Marieke J van der Werf; Mina Gaga; Daniela Cirillo; Antonio Spanevello; Mario Raviglione; Francesco Blasi; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2014-01-03       Impact factor: 16.671

7.  Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.

Authors:  Andrea Pantoja; Christopher Fitzpatrick; Anna Vassall; Karin Weyer; Katherine Floyd
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

Review 8.  Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

Authors:  Peter MacPherson; Rein M G J Houben; Judith R Glynn; Elizabeth L Corbett; Katharina Kranzer
Journal:  Bull World Health Organ       Date:  2013-11-22       Impact factor: 9.408

9.  Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Authors:  Nicolas A Menzies; Ted Cohen; Hsien-Ho Lin; Megan Murray; Joshua A Salomon
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069
  9 in total
  6 in total

1.  Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.

Authors:  Samuel G Schumacher; William A Wells; Mark P Nicol; Karen R Steingart; Grant Theron; Susan E Dorman; Madhukar Pai; Gavin Churchyard; Lesley Scott; Wendy Stevens; Pamela Nabeta; David Alland; Karin Weyer; Claudia M Denkinger; Christopher Gilpin
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

2.  The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa.

Authors:  Sabine Hermans; Judy Caldwell; Richard Kaplan; Frank Cobelens; Robin Wood
Journal:  Bull World Health Organ       Date:  2017-04-28       Impact factor: 9.408

3.  Assessing the quality of tuberculosis care using routine surveillance data: a process evaluation employing the Zero TB Indicator Framework in Mongolia.

Authors:  Ariunzaya Saranjav; Christina Parisi; Davaasambuu Ganmaa; J Lucian Davis; Xin Zhou; Khulan Dorjnamjil; Tumurkhuyag Samdan; Sumiya Erdenebaatar; Altantogoskhon Chuluun; Tserendagva Dalkh; Gantungalag Ganbaatar; Meredith B Brooks; Donna Spiegelman
Journal:  BMJ Open       Date:  2022-08-16       Impact factor: 3.006

Review 4.  Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach.

Authors:  Theresa Ryckman; Katherine Robsky; Lucia Cilloni; Stella Zawedde-Muyanja; Ramya Ananthakrishnan; Emily A Kendall; Sourya Shrestha; Stavia Turyahabwe; Achilles Katamba; David W Dowdy
Journal:  Lancet Infect Dis       Date:  2022-08-10       Impact factor: 71.421

Review 5.  Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.

Authors:  Gwenan M Knight; Nila J Dharan; Gregory J Fox; Natalie Stennis; Alice Zwerling; Renuka Khurana; David W Dowdy
Journal:  Int J Infect Dis       Date:  2015-11-03       Impact factor: 3.623

Review 6.  Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies.

Authors:  Samuel G Schumacher; Hojoon Sohn; Zhi Zhen Qin; Genevieve Gore; J Lucian Davis; Claudia M Denkinger; Madhukar Pai
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.